SEI Medical PCL (BKK:SEI) ROCE %: 12.46% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:SEI SEI Medical PCL BKK:SEI
19 GF Score
Price ฿1.78
! 3 Warning Signs
View Full Analysis

What is SEI Medical PCL ROCE %?

SEI Medical PCL BKK:SEI -1.66% 19 ROCE % is 12.46% as of Mar. 2026. GuruFocus rates BKK:SEI with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SEI Medical PCL's annualized ROCE % for the quarter that ended in Mar. 2026 was 12.46%.

SEI Medical PCL  (BKK:SEI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SEI Medical PCL ROCE % Related Terms

SEI Medical PCL ROCE % Historical Data

* Premium members only.

The historical data trend for SEI Medical PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SEI Medical PCL ROCE % Chart

SEI Medical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
63.56 39.64 32.01 18.74

SEI Medical PCL Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.97 12.87 17.29 9.30 12.46
BKK:SEI
19GF Score
SEI Medical PCL BKK:SEI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SEI Medical PCL ROCE % Calculation

SEI Medical PCL's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=60.627/( ( (461.105 - 147.596) + (514.986 - 181.301) )/ 2 )
=60.627/( (313.509+333.685)/ 2 )
=60.627/323.597
=18.74 %

SEI Medical PCL's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=41.98/( ( (514.986 - 181.301) + (519.977 - 179.607) )/ 2 )
=41.98/( ( 333.685 + 340.37 )/ 2 )
=41.98/337.0275
=12.46 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.46% mean?
SEI Medical PCL (BKK:SEI) has a ROCE % of 12.46% as of Mar. 2026.
Is SEI Medical PCL's ROCE % too high?
SEI Medical PCL's current ROCE % is 12.46%. The Medical Distribution industry median ROCE % is 9.09. SEI Medical PCL's value of 12.46% is 37.1% above this industry median. Overall, SEI Medical PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SEI Medical PCL's ROCE % compare to MCK and CAH?
SEI Medical PCL's ROCE % of 12.46% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.09. SEI Medical PCL's value of 12.46% is 37.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.09, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SEI Medical PCL's current ROCE % of 12.46% is 37.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SEI Medical PCL's current ROCE % is 12.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SEI Medical PCL stock overvalued right now?
SEI Medical PCL (BKK:SEI) has a current ROCE % of 12.46%. The current ROCE % is 12.46% and 37.1% above the Medical Distribution industry median of 9.09. SEI Medical PCL's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For SEI Medical PCL (BKK:SEI), the current ROCE % is 12.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SEI Medical PCL Business Description

Address Ratchadaphisek Road, No. 546 Ratchada One Building, 7th Floor, Chankasem, Chatuchak District, Bangkok, THA, 10900
SEI Medical PCL operates in the medical equipment and scientific products industry as a distributor and service provider of medical equipment. It has three reportable segments which are the sales of equipment related to scientific instruments and medical equipment, the related service segment and the medical equipment disposal segment. The main geographic which the company operates is Thailand. Key revenue is collected from the Disposal Segment.
19GF Score

Get the complete analysis for BKK:SEI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.78
Price